Schering-Plough
SGP
#508
Rank
โ‚ฌ40.08 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: โ‚ฌ1.77 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of โ‚ฌ1.77 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008โ‚ฌ1.77 B
2006โ‚ฌ1.28 B198.39%
2005โ‚ฌ0.43 B-395.83%
2004-โ‚ฌ0.15 Billion265.22%
2003-โ‚ฌ39.92 Million-102.01%
2002โ‚ฌ1.98 B3.62%
2001โ‚ฌ1.91 B-5.39%
2000โ‚ฌ2.02 B
1998โ‚ฌ1.67 B22.34%
1997โ‚ฌ1.36 B38.9%
1996โ‚ฌ0.98 B